This site may receive compensation from the provider linked above. Full disclosure.
Weight loss and GLP-1 providers currently serving Sevier County, Arkansas — sourced from Google Business listings.
Weight loss service
141 Forks of the River Pkwy, Sevierville, TN 37862
Weight loss service
1360 Dolly Parton Pkwy, Sevierville, TN 37862
Weight loss service
1235 Dolly Parton Pkwy #1, Sevierville, TN 37862
Business listings sourced from Google Maps. Information may not be current.
Sevier County is a county in Arkansas with a population of approximately 17,007 residents. Our telehealth platform connects patients across all communities in Sevier County with board-certified physicians who can prescribe FDA-approved GLP-1 medications online. Arkansas leads the nation in rural obesity rates, with limited access to in-person bariatric specialists across its 75 counties. Ozark Mountain communities and Delta farmland regions have some of the highest obesity concentrations in the US.
GLP-1 receptor agonists — including semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) — are clinically proven weight loss medications. Arkansas ranks 2nd in adult obesity nationally at 35.0% (CDC 2023), with type 2 diabetes affecting over 12% of adults statewide. Patients in Sevier County can now access these treatments through a simple online consultation, without the need to travel to an in-person clinic.
Access Ozempic, Wegovy, Mounjaro, and Zepbound — all FDA-approved GLP-1 medications proven to support significant weight loss in clinical trials.
All prescribing physicians in our network hold active Arkansas medical licenses. Consultations comply with Arkansas telehealth law (Arkansas Code § 17-80-402).
Our simple 3-step process makes getting a GLP-1 prescription easy for Sevier County residents.
GLP-1 telehealth services are available across all Arkansas counties. Browse neighboring counties below.
Explore GLP-1 telehealth availability across Arkansas's major cities.
Yes. Arkansas law permits telehealth prescriptions for GLP-1 medications after a proper clinical evaluation under Arkansas Code § 17-80-402. Our network of Arkansas-licensed physicians can complete your consultation online and send a prescription to your preferred pharmacy in Sevier County or arrange home delivery.
Patients in Sevier County can be prescribed semaglutide (Ozempic®, Wegovy®), tirzepatide (Mounjaro®, Zepbound®), and liraglutide (Saxenda®) — all FDA-approved GLP-1 receptor agonists indicated for weight management. Your physician will recommend the most appropriate option based on your health profile.
Consultation fees vary by provider, typically ranging from $0 to $199 for the initial visit. Medication costs depend on insurance coverage, manufacturer savings programs, and pharmacy choice. Many patients in Arkansas qualify for significant savings through patient assistance programs.
After completing your online health assessment, most patients in Sevier County receive a physician response within 24–48 hours. If approved, your prescription can be sent to a pharmacy near you in Sevier County or shipped directly to your home within 2–5 business days.
Sevier County has several local weight loss clinics and medical practices that may offer GLP-1 treatments in person. However, our telehealth service provides the same quality of care from the convenience of your home, with licensed Arkansas physicians available to patients throughout Sevier County.
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
Medically reviewed by
Dr. Sarah Mitchell, MD, ABOM
Board-Certified in Obesity Medicine • Last reviewed: June 5, 2026
Black Box Warning: In rodent studies, semaglutide and tirzepatide caused thyroid C-cell tumors. It is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and injection site reactions. These typically diminish as dosage is gradually escalated.
Serious side effects may include pancreatitis, gallbladder problems, kidney injury, hypoglycemia (with insulin), and allergic reactions. Consult your healthcare provider immediately if you experience severe symptoms.
Contraindications: History of medullary thyroid carcinoma, MEN 2, pancreatitis, pregnancy or breastfeeding, severe gastrointestinal disease. This is not a complete list — always discuss your full medical history with your physician.
Clinical References:
